PD-L1 Inhibitor Nivolumab Works Well in New Mesothelioma Study
A study of the PD-L1 inhibitor nivolumab showed “safety and efficacy” in mesothelioma patients who failed with other treatments. Nivolumab…
Possible New Drug for Mesothelioma Gets First FDA Approval
A possible new drug for mesothelioma has received FDA approval for the treatment of advanced epithelioid sarcoma. Tazemetostat (Tazverik) is…
Second Line Mesothelioma Treatment Shot Down in New Study
Italian researchers say there is good news and bad news about a proposed second line mesothelioma treatment. The good news…
Injectable Pemetrexed for Mesothelioma Now Available for the First Time
The FDA has cleared injectable pemetrexed for mesothelioma after two drug companies settled a patent dispute over the medication in…
Europe | International | New Drugs | New Studies | Research | Treatments
Sarcomatoid Mesothelioma Treatment Focuses on Two-Drug Combo
Researchers in Spain are developing what they hope will be a more effective sarcomatoid mesothelioma treatment. The new treatment focuses…
Alternatives | Europe | International | New Drugs | Treatments | Updates
Anti-Inflammatory Treatment for Mesothelioma Shows Long-Term Benefit
Doctors in London are reporting a case of long-term mesothelioma survival with anti-inflammatory treatment for mesothelioma. The 64-year-old pleural mesothelioma…
Europe | International | New Drugs | New Studies | Research | Treatments
Second-Line Treatment for Mesothelioma with Lurbinectedin
Swiss researchers may have finally found an effective second-line treatment for mesothelioma. Scientists with the Swiss Group for Clinical Cancer…
New Mesothelioma Immunotherapy Trial Now Underway at Baylor
Cancer researchers at Baylor College of Medicine have launched a new mesothelioma immunotherapy trial. The trial combines the cancer drug…
Chemotherapy | New Drugs | New Studies | Research | Treatments | Updates
Cediranib for Mesothelioma: VEGF Inhibitor Fails Another Trial
Cediranib for mesothelioma appears to be ruled out by another failed clinical trial. A new study led by MD Anderson…
Asia | International | New Drugs | New Studies | Prevention | Research | Treatments
Experimental Mesothelioma Treatment Targets Tumor Growth Compounds
Hong Kong researchers have released the first results of an experimental mesothelioma treatment they are working on. The treatment targets…